Literature DB >> 9203663

Phospholipase activity in Cryptococcus neoformans: a new virulence factor?

S C Chen1, M Muller, J Z Zhou, L C Wright, T C Sorrell.   

Abstract

Fifty isolates of Cryptococcus neoformans were examined for extracellular phospholipase production after inoculation onto egg yolk agar; 49 produced a pericolonial precipitate indicative of phospholipase activity. Phospholipase B (PLB), lysophospholipase, and lysophospholipase-transacylase activities were identified by radiometric analysis in supernatants from 4 clinical isolates. The ratio of colony diameter to colony plus precipitate on agar (Pz) correlated with PLB activity. Phospholipase production was similar in 12 environmental and 13 clinical isolates of C. neoformans var. gattii. Environmental strains of C. neoformans var. neoformans (n = 8) produced more phospholipase at 72 h than did 17 clinical isolates (mean Pz, 0.57 vs. 0.72; P < .01); however, Pz values were similar at 96 h. Quantitation of cryptococci in the lungs and brains of BALB/c mice inoculated intravenously with 4 strains expressing high, intermediate, or low phospholipase activity revealed a correlation between phospholipase activity and virulence. Phospholipases secreted by C. neoformans may be implicated in virulence.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9203663     DOI: 10.1093/infdis/175.2.414

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  50 in total

1.  In vitro antifungal activities of bis(alkylpyridinium)alkane compounds against pathogenic yeasts and molds.

Authors:  Sharon C-A Chen; Chayanika Biswas; Robyn Bartley; Fred Widmer; Namfon Pantarat; Daniel Obando; Julianne T Djordjevic; David H Ellis; Katrina A Jolliffe; Tania C Sorrell
Journal:  Antimicrob Agents Chemother       Date:  2010-06-07       Impact factor: 5.191

2.  In vitro antifungal activities of inhibitors of phospholipases from the fungal pathogen Cryptococcus neoformans.

Authors:  Ranjini Ganendren; Fred Widmer; Vatsala Singhal; Christabel Wilson; Tania Sorrell; Lesley Wright
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

3.  Pleiotropic function of intersectin homologue Cin1 in Cryptococcus neoformans.

Authors:  Gui Shen; Amy Whittington; Kejing Song; Ping Wang
Journal:  Mol Microbiol       Date:  2010-03-16       Impact factor: 3.501

4.  Characterization of a flocculation-like phenotype in Cryptococcus neoformans and its effects on pathogenesis.

Authors:  Li Li; Oscar Zaragoza; Arturo Casadevall; Bettina C Fries
Journal:  Cell Microbiol       Date:  2006-06-07       Impact factor: 3.715

5.  Hexadecylphosphocholine (miltefosine) has broad-spectrum fungicidal activity and is efficacious in a mouse model of cryptococcosis.

Authors:  Fred Widmer; Lesley C Wright; Daniel Obando; Rosemary Handke; Ranjini Ganendren; David H Ellis; Tania C Sorrell
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

6.  Neurovirulence of Cryptococcus neoformans determined by time course of capsule accumulation and total volume of capsule in the brain.

Authors:  A Pool; L Lowder; Y Wu; K Forrester; J Rumbaugh
Journal:  J Neurovirol       Date:  2013-06-04       Impact factor: 2.643

7.  The Outcome of the Cryptococcus neoformans-Macrophage Interaction Depends on Phagolysosomal Membrane Integrity.

Authors:  Carlos M De Leon-Rodriguez; Diego C P Rossi; Man Shun Fu; Quigly Dragotakes; Carolina Coelho; Ignacio Guerrero Ros; Benjamin Caballero; Sabrina J Nolan; Arturo Casadevall
Journal:  J Immunol       Date:  2018-06-01       Impact factor: 5.422

8.  New insights on the pathogenesis of invasive Cryptococcus neoformans infection.

Authors:  Helene C Eisenman; Arturo Casadevall; Erin E McClelland
Journal:  Curr Infect Dis Rep       Date:  2007-11       Impact factor: 3.725

9.  Cryptococcal phospholipases: a novel lysophospholipase discovered in the pathogenic fungus Cryptococcus gattii.

Authors:  Lesley C Wright; Jackie Payne; Rosemary T Santangelo; Mukoma F Simpanya; Sharon C A Chen; Fred Widmer; Tania C Sorrell
Journal:  Biochem J       Date:  2004-12-01       Impact factor: 3.857

10.  CNLAC1 is required for extrapulmonary dissemination of Cryptococcus neoformans but not pulmonary persistence.

Authors:  Mairi C Noverr; Peter R Williamson; Ryan S Fajardo; Gary B Huffnagle
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.